Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade L Thorstad

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 5, 2022
Osteonectin/SPARC Expression in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray StudyJames S Lewis, Wade L Thorstad, Mohammad Hussaini
Seminars in Nuclear Medicine|August 22, 2003
Role of fusion in radiotherapy treatment planningArnold C Paulino, Wade L Thorstad, Timothy Fox
Seminars in Oncology|January 17, 2004
Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary dataWade L Thorstad, Bruce Haughey, K S Clifford Chao
Seminars in Oncology|February 24, 2005
Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancerWade L Thorstad, K S Clifford Chao, Bruce Haughey
Head and Neck Pathology|November 27, 2012
B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinomaOdey C Ukpo, Wade L Thorstad, James S Lewis
The American Journal of Surgical Pathology|June 30, 2012
Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancersJames S Lewis, Juliette B Scantlebury, Jingqin Luo, et al.
The American Journal of Surgical Pathology|October 23, 2013
A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinomaJames S Lewis, Sahirzeeshan Ali, Jingqin Luo, et al.
Oral Oncology|August 12, 2017
Trials in head and neck oncology: Evolution of perioperative adjuvant therapyJoseph Zenga, Patrik Pipkorn, Douglas R Adkins, et al.
Oral Oncology|October 1, 2016
Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes?Parul Sinha, Patrik Pipkorn, Wade L Thorstad, et al.
Physics in Medicine and Biology|March 1, 2007
IMRT treatment planning based on prioritizing prescription goalsJan J Wilkens, James R Alaly, Konstantin Zakarian, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 5, 2022
Osteonectin/SPARC Expression in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray StudyJames S Lewis, Wade L Thorstad, Mohammad Hussaini
Seminars in Nuclear Medicine|August 22, 2003
Role of fusion in radiotherapy treatment planningArnold C Paulino, Wade L Thorstad, Timothy Fox
Seminars in Oncology|January 17, 2004
Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: preliminary dataWade L Thorstad, Bruce Haughey, K S Clifford Chao
Seminars in Oncology|February 24, 2005
Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancerWade L Thorstad, K S Clifford Chao, Bruce Haughey
Head and Neck Pathology|November 27, 2012
B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinomaOdey C Ukpo, Wade L Thorstad, James S Lewis
The American Journal of Surgical Pathology|June 30, 2012
Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancersJames S Lewis, Juliette B Scantlebury, Jingqin Luo, et al.
The American Journal of Surgical Pathology|October 23, 2013
A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinomaJames S Lewis, Sahirzeeshan Ali, Jingqin Luo, et al.
Oral Oncology|August 12, 2017
Trials in head and neck oncology: Evolution of perioperative adjuvant therapyJoseph Zenga, Patrik Pipkorn, Douglas R Adkins, et al.
Oral Oncology|October 1, 2016
Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes?Parul Sinha, Patrik Pipkorn, Wade L Thorstad, et al.
Physics in Medicine and Biology|March 1, 2007
IMRT treatment planning based on prioritizing prescription goalsJan J Wilkens, James R Alaly, Konstantin Zakarian, et al.
Pageof 10